Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction Elaine Monteiro Matsuda; Ivana Barros Campos; Isabela Penteriche de Oliveira; Daniela Rodrigues Colpas; Giselle Ibete Silva López-Lopes; Victor Oliveira Chiavegato; Luís Fernando de Macedo Brígido;

Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials Elahe Akbari; Masoud Seyedinkhorasani; Azam Bolhassani;

HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region Myuki Alfaia Esashika Crispim; Monica Nogueira da Guarda Reis; Mariane Martins de Araujo Stefani;